Literature DB >> 12974208

Simultaneous assays for Clostridium difficile and faecal lactoferrin in ulcerative colitis.

Chetana Vaishnavi1, Rakesh Kochhar, Deepak Bhasin, Kandavel Thennarasu, Kartar Singh.   

Abstract

Infectious agents may be one of the important factors in initiating or perpetuating ulcerative colitis. Increasing evidence has accumulated regarding the role of Clostridium difficile (C. difficile) infection in the exacerbation of ulcerative colitis. The present work was undertaken to study the implications of C. difficile toxin (CDT) and faecal lactoferrin (FL) positivity in patients with idiopathic ulcerative colitis (IUC) in a north Indian hospital. Ninety-four faecal samples from patients of IUC were processed for CDT and FL simultaneously. Clinical details of patients, including antibiotic intake in the past 6 weeks, were recorded. Eighty-one of the 94 patients (86.2%) had diarrhoea and 48 (51.1%) had received antibiotics. There was a statistically significant (p < 0.001) increase in the prevalence of diarrhoea among individuals receiving antibiotics. Twelve of the 94 samples (12.8%) were CDT positive while 16 were FL positive. No statistical significance (p > 0.05) was seen while comparing the positivity of CDT and FL in relation to the receipt of antibiotics. A statistically significant (p < 0.001) positive correlation was present between CDT and FL assays. FL positivity in IUC may depend on the intestinal inflammation precipitated by C. difficile infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12974208

Source DB:  PubMed          Journal:  Trop Gastroenterol        ISSN: 0250-636X


  7 in total

Review 1.  Clostridium difficile infection: clinical spectrum and approach to management.

Authors:  Chetana Vaishnavi
Journal:  Indian J Gastroenterol       Date:  2011-12-20

2.  Correlation between coinfection with parasites, cytomegalovirus, and Clostridium difficile and disease severity in patients with ulcerative colitis.

Authors:  Venkatakrishnan H Iyer; Joby Augustine; Anna B Pulimood; Sitara Swarna Rao Ajjampur; Balakrishnan S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2013-02-14

3.  Indian Society of Gastroenterology consensus on ulcerative colitis.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Philip Abraham; Uday C Ghoshal; Venkataraman Jayanthi; Brij Kishore Agarwal; Vineet Ahuja; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra C Desai; Gopal Krishna Dhali; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Ajay Kumar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Anna Pulimood; Amarender S Puri; Ganesh N Ramesh; Gautam Ray; Shivaram P Singh; Ajit Sood; Manu Tandan
Journal:  Indian J Gastroenterol       Date:  2012-10-25

Review 4.  Fidaxomicin--the new drug for Clostridium difficile infection.

Authors:  Chetana Vaishnavi
Journal:  Indian J Med Res       Date:  2015-04       Impact factor: 2.375

5.  Toxigenic Clostridium difficile isolates from clinically significant diarrhoea in patients from a tertiary care centre.

Authors:  Meenakshi Singh; Chetana Vaishnavi; Rakesh Kochhar; Safrun Mahmood
Journal:  Indian J Med Res       Date:  2017-06       Impact factor: 2.375

Review 6.  Systematic Literature Review on Burden of Clostridioides difficile Infection in India.

Authors:  Canna J Ghia; Shaumil Waghela; Gautam S Rambhad
Journal:  Clin Pathol       Date:  2021-05-31

Review 7.  Inflammatory bowel disease in India - Past, present and future.

Authors:  Gautam Ray
Journal:  World J Gastroenterol       Date:  2016-09-28       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.